Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Indicators showing possible reversal today.
Many false signals before with IWEB so must wait for close to confirm.
GLTA.
I agree.
Somewhat confusing to me & I would appreciate if anyone with a greater understanding of this strategy could explain?
Extra authorized shares could be related in some way to Antigen spinoff? As well, perhaps an Antigen partnership will be announced prior to enacting reverse split so as to transact at a higher price?
In any event CEO was very clear that the company is planning to pursue a reverse split.
Yes.
CEO stated clearly that the Board & Management believes a reverse-split is in the best interest of the company and that it will most likely be implemented.
He did not say when the reverse-spit will take place however I believe this is the reason for a lack of follow through on yesterdays move.
Long term prospects of the company appear stronger than ever.
Most important IMO is the possibility of partnerships for Antigen which was again referenced in today's CC.
GLTA.
How about this for Fair Value?
"I think this research is worth half-a-billion minimum."
"It could be argued that even this number ($500 million) represents a hugely discounted price (after all, it is 83% less than the $2.8 billion Pfizer spent). The insulin market has not gone away. Generex's current market cap of $23.44 million is absurdly, ridiculously low."
http://seekingalpha.com/article/1145681-generex-research-for-sale-on-the-cheap?source=yahoo
Fair Market Value?
What is fair market value for a company conducting a Phase 3 Breast Cancer trial with $10+ Billion market potential?
Much higher than $24 Million I would think?
What is fair market value for a company conducting a Phase 3 Breast Cancer trial with $10+ Billion market potential?
Much higher than $20 Million I believe.
Based on what indicator?
The current price reflects collective market assessment of value at a given moment in time.
The current price is .061
GLTY.
Market thinks stock is worth the risk at .06.
Kudos to Howe for following up with a positive tone and some optimism after Fridays dreary letter.
Lets hope that 2013 will be the turnaround year many have been waiting for?
Happy New Year & GLTA.
Less than $100K rev in 4th Q.
Based on Howe's comments I assume this means October shipments were at least $150K?
Not an encouraging set of developments no matter how you slice it.
Regardless of how things are moving along currently, this is perhaps the single worst shareholder letter I have ever read.
The CEO sounds agitated by shareholders "repeatedly" asking about company progress and offered no insight into current business conditions.
Without additional pumping Oldguy will have his chance to load up under .05 on Monday.
Happy New Year & GLTA.
Last years IWEB XMAS card from Signorello is a poignant reminder that life is so much more than the price of a stock. My prayers go out to his family who are enduring their first Christmas without him.
Take time today to count your blessings.
God Bless & Merry Christmas.
Penny stocks are not 'great trading stocks' unless you enjoy flipping sub-$5000 positions.
Penny stocks are speculative and highly unpredictable for use as practical trading vehicles.
'Traders' prefer much more liquidity than penny stocks can offer.
GLTY.
FYI:
Lyle L. Probst, Vice President, Operations & Product Development
Lyle L. Probst has over 10 years of program management experience at MicroFluidic Systems and Lawrence Livermore National Laboratory (LLNL), and principal investigator/developer of the high-throughput BioWatch mobile laboratory at SAIC.
FYI:
Lyle L. Probst, Vice President, Operations & Product Development
Lyle L. Probst has over 10 years of program management experience at MicroFluidic Systems and Lawrence Livermore National Laboratory (LLNL), and principal investigator/developer of the high-throughput BioWatch mobile laboratory at SAIC.
I am realistic as well.
I beleive Howe was off base using language like "...brought us to this new point in the Company’s history in record time" only to share very little with shareholders.
Dissapointed with todays Webcast.
I expected more than "we have a great new product" and "our sales are going great".
By promoting todays Webcast as he did, the CEO hinted he may offer some 'real' information pertaining to sales, revenue, indebetness, fiscal improvement but offered little if any substance.
Memo to CEO: No more Webcasts until you have real results to share.
IMO
Realase of new product info effetively dampened speculative trading activity prior to CC.
Nice setup if they actually have something bullish to disclose.
IMO
Strong buy signal triggered with today's weekly close.
Uptrend confirmation on Monthly chart.
Triple confirmation of Aug. 17th buy signal.
Indicators point to a significant reversal.
IMO.
Someone is accumulating large blocks at. 09.
Nice setup for Monday.
Weekly indicators showing many bullish divergences.
Excellent point.
Two intriguing items from today's PR:
1. C.C. taking place at beginning of trading week during trading hours. Typically a bullish indicator.
2. This line from the press release insinuates they may actually have 'significant' news to announce:
"Also, be aware that I am bound by SEC regulations about how much information I can discuss."
Confirmation of Aug. 17th buy signal with todays action.
Chart looks good and a relatively strong floor of support is established.
All we need is some primer.
IMO
Glad to see you will at least wait "until he fails" to criticize the new CEO.
LOL.
Please accept my apology for misreading your post.
In any event, IWEB is a company and not a cat so your 'metaphor' still does not hold water.
Why would a CEO who has only been with a company a month give guidance? Any thought that he would was delusional and showed no comprehension of the responsibilities of an executive.
I posted with ALL CAPS to point out the foolishness that .074 is somehow a 'ceiling'.
On another note, IWEB is still in business (ie, not dead), whereas a dead cat is actually dead.
GLTY.
ALERT, ALERT!
IWEB trading above the .074 'ceiling'.
LOL!
Thanks Prudent.
I agree with you 100%.
In fact, I will go out on a limb and say there is no 'factual basis' for much of the 'information' disseminated on this board.
So you are on record that IWEB will never trade above .074?
Thanks for the advice!
Sounds like this whole 'cashless exercise warrant' thing is a complete mess.
When something is this messy, the best course of action for those unsure and overly concerned is to stay away from the investment.
Nice close on weekly chart.
26 EMA on daily at .075 turning up / RSI above 50.
Stock has found support and a bottom is in.
All IMO of course.
MM's will work for a weekly close below .07.
.109 trade earlier this week created a false high to delay strong buy signals should webcast fail to generate upside momentum.
Not making any suggestions as to your personal strategy. Just sharing what your options are.
There are really only three choices when investing/trading an equity issue:
1 = Go long
2 = Go short
3 = Stay out
I strongly recommend making one of these choices based on all available information.
GLTY.
He said things are going well but offered no guidance.
Those who expected him to offer some form of guidance are selling.
Buy signal triggered today (moderate strength signal using my proprietary system).
A weekly close above .07 next week will signal strong reversal.
Set stops below .05.
Then you are in luck.
There is a webcast in one week to help sort our all of this pesky confusion.
I suppose we shall find out on Aug. 23rd?